Last reviewed · How we verify
Tums — Competitive Intelligence Brief
marketed
Antacid, Calcium supplement
Gastric acid (direct neutralization)
Cardiovascular
Inorganic salt
Live · refreshed every 30 min
Target snapshot
Tums (calcium carbonate) — Generic (multiple manufacturers).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tums TARGET | calcium carbonate | Generic (multiple manufacturers) | marketed | Antacid, Calcium supplement | Gastric acid (direct neutralization) | 1930-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antacid, Calcium supplement class)
- Generic (multiple manufacturers) · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tums CI watch — RSS
- Tums CI watch — Atom
- Tums CI watch — JSON
- Tums alone — RSS
- Whole Antacid, Calcium supplement class — RSS
Cite this brief
Drug Landscape (2026). Tums — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-carbonate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing